Lista de obras -

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function

artículo científico publicado en 2013

Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial

artículo científico publicado en 2020

Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy

artículo científico publicado en 2012

Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.

artículo científico publicado en 2014

Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure

artículo científico publicado en 2014

Clinical implications of chronic heart failure phenotypes defined by cluster analysis

artículo científico publicado en 2014

Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of care

artículo científico publicado en 2008

Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.

artículo científico publicado en 2016

Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers

artículo científico publicado en 2002

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

artículo científico

Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

artículo científico publicado en 2017

Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes

artículo científico publicado en 2018

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure

artículo científico publicado en 2018

Economic effects of beta-blocker therapy in patients with heart failure

artículo científico publicado en 2004

Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure

artículo científico publicado en 2010

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

artículo científico publicado en 2017

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial

artículo científico

Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure

artículo científico publicado en 2004

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial

artículo científico publicado en 2012

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial

artículo científico publicado en 2009

Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial

artículo científico publicado en 2017

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

artículo científico publicado en 2009

Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure

artículo científico publicado en 2015

Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)

artículo científico publicado en 2013

Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives

artículo científico publicado en 2006

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

artículo científico publicado en 2011

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale

artículo científico publicado en 2007

Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory

artículo científico publicado en 2018

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure

artículo científico publicado en 2015

Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial

artículo científico publicado en 2018

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study

artículo científico publicado en 2009

Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction

scientific article published on 01 September 2019

Outcomes in heart failure patients after major noncardiac surgery

artículo científico publicado en 2004

Predicting significant coronary artery disease in patients with left ventricular dysfunction

artículo científico publicado en 2006

Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines

artículo científico publicado en 2011

Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training

artículo científico publicado en 2015

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure

artículo científico publicado en 2014

Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale

artículo científico publicado en 2016

Relation between volume of exercise and clinical outcomes in patients with heart failure

artículo científico publicado en 2012

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION

scientific article published on 31 August 2018

Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

scientific article published on 11 October 2010

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes

artículo científico publicado en 2013

The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure

artículo científico publicado en 2013

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study

artículo científico publicado en 2017

Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF.

artículo científico publicado en 2012

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

artículo científico publicado en 2013

Lista de obras de

Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function

Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial

Association between adrenergic receptor genotypes and beta-blocker dose in heart failure patients: analysis from the HF-ACTION DNA substudy

Associations between seattle heart failure model scores and medical resource use and costs: findings from HF-ACTION.

Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure

Clinical implications of chronic heart failure phenotypes defined by cluster analysis

Delivering heart failure disease management in 3 tertiary care centers: key clinical components and venues of care

Dichotomous Relationship Between Age and 30-Day Death or Rehospitalization in Heart Failure Patients Admitted With Acute Decompensated Heart Failure: Results From the ASCEND-HF Trial.

Disease management in healthcare organizations: results of in-depth interviews with disease management decision makers

Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF.

Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

Dose Response of β-Blockers in Adrenergic Receptor Polymorphism Genotypes

Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure

Economic effects of beta-blocker therapy in patients with heart failure

Economic evaluation of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) randomized controlled trial: an exercise training study of patients with chronic heart failure

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial

Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure

Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial

Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial

Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Evaluation of the Incremental Prognostic Utility of Increasingly Complex Testing in Chronic Heart Failure

Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)

Financial implications of a model heart failure disease management program for providers, hospital, healthcare systems, and payer perspectives

Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study

Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale

Improving Heart Failure Therapeutics Development in the United States: The Heart Failure Collaboratory

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with heart failure

Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial

N-terminal pro-brain natriuretic peptide and exercise capacity in chronic heart failure: data from the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) study

Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction

Outcomes in heart failure patients after major noncardiac surgery

Predicting significant coronary artery disease in patients with left ventricular dysfunction

Predictors of hospital length of stay in heart failure: findings from Get With the Guidelines

Prognostic significance of depression in blacks with heart failure: insights from Heart Failure: a Controlled Trial Investigating Outcomes of Exercise Training

Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure

Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale

Relation between volume of exercise and clinical outcomes in patients with heart failure

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION

Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007.

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes

The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Utility of Growth Differentiation Factor-15, A Marker of Oxidative Stress and Inflammation, in Chronic Heart Failure: Insights From the HF-ACTION Study

Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF.

Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).